Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2026-01-26 @ 11:15 AM
Study NCT ID:
NCT02555306
Status:
COMPLETED
Last Update Posted:
2020-01-14
First Post:
2015-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration
Sponsor:
Organization: